Pfizer Inc (PFE)

49.20
-0.04(-0.08%)
  • Volume:
    100
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    49.16 - 49.20
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035

PFE Overview

Prev. Close
49.24
Day's Range
49.16-49.2
Revenue
-
Open
49.16
52 wk Range
31.51-54.55
EPS
-
Volume
100
Market Cap
278.9B
Dividend (Yield)
1.29
(3.34%)
Average Vol. (3m)
350
P/E Ratio
-
Beta
-
1-Year Change
49.76%
Shares Outstanding
5,610,895,801
Next Earnings Date
Aug 02, 2022
What is your sentiment on Pfizer?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • Can Pfizer exceed $100? The answer is absolutely not! That's because the puppy has to acquire other companies, and that's going to cost a lot of money. After CIVID-19 is over, this puppy will be worthless.
    2
    • don't keep uploading PFE!! wait that I enlarge my pockets!! To The Moon 🚀🚀🚀
      0
      • sht up this company will fall again when the covid 19 ends
        1
    • Why did Pfizer lie about vaccine effectiveness? The stock price tells the truth.
      2
      • Lol! Yes, Ray/peter pan! We can see how smart you are. You don't get tired of proving yourself!
        0
    • If you want to short a stock without the hassle, I believe Pfizer is the best bet.
      5
      • MERCK continues to rise, but Pfizer falls. That's why Buffett chooses Merck.
        4
        • Pfizer is a dead cat bounce.
          2
          • Pfizer seems attractively positioned technically for a bounce and might try to fill gaps.
            3
            • Pfizer's forward earnings should decline dramatically as there is less of a need for their vaccine and/or their therapeutic drug. 1Q was a "transition" to much lower earnings.
              2
              • why Moderna goes up so quick, but Pfizer can't. I think the insiders manipulate the stock price.
                7
                • just stop
                  1
              • solid good company
                4